JP2010540564A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010540564A5 JP2010540564A5 JP2010527251A JP2010527251A JP2010540564A5 JP 2010540564 A5 JP2010540564 A5 JP 2010540564A5 JP 2010527251 A JP2010527251 A JP 2010527251A JP 2010527251 A JP2010527251 A JP 2010527251A JP 2010540564 A5 JP2010540564 A5 JP 2010540564A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- eye
- ocular
- scaav
- interfering rna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97655207P | 2007-10-01 | 2007-10-01 | |
| PCT/US2008/078380 WO2009046059A1 (en) | 2007-10-01 | 2008-10-01 | Self complementary aav-mediated delivery of interfering rna molecules to treat or prevent ocular disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010540564A JP2010540564A (ja) | 2010-12-24 |
| JP2010540564A5 true JP2010540564A5 (enExample) | 2012-09-13 |
Family
ID=40042637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010527251A Pending JP2010540564A (ja) | 2007-10-01 | 2008-10-01 | 自己相補的なａａｖが媒介する眼の障害を処置または予防するための干渉ｒｎａ分子の送達 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20090087413A1 (enExample) |
| EP (1) | EP2192926A1 (enExample) |
| JP (1) | JP2010540564A (enExample) |
| KR (1) | KR20100061792A (enExample) |
| CN (1) | CN101815536A (enExample) |
| AU (1) | AU2008308784B2 (enExample) |
| BR (1) | BRPI0817937A2 (enExample) |
| CA (1) | CA2694091A1 (enExample) |
| MX (1) | MX2010001608A (enExample) |
| RU (1) | RU2010117178A (enExample) |
| WO (1) | WO2009046059A1 (enExample) |
| ZA (1) | ZA201000423B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2019143A1 (en) | 2007-07-23 | 2009-01-28 | Genethon | CNS gene delivery using peripheral administration of AAV vectors |
| EP2058401A1 (en) | 2007-10-05 | 2009-05-13 | Genethon | Widespread gene delivery to motor neurons using peripheral injection of AAV vectors |
| EP2287323A1 (en) | 2009-07-31 | 2011-02-23 | Association Institut de Myologie | Widespread gene delivery to the retina using systemic administration of AAV vectors |
| HUE041571T2 (hu) | 2010-04-23 | 2019-05-28 | Univ Florida | RAAV-guanilát-cikláz-készítmények és ejárások 1-es típusú Leber-féle veleszületett vakság (LCA1) kezelésére |
| CN103505743A (zh) * | 2012-06-21 | 2014-01-15 | 北京命码生科科技有限公司 | 含功能性microRNA/siRNA的细胞微粒子及其应用 |
| EP4012035B1 (en) * | 2014-09-16 | 2024-11-06 | Genzyme Corporation | Adeno-associated viral vectors for treating myocilin (myoc) glaucoma |
| PT4012035T (pt) * | 2014-09-16 | 2025-02-11 | Genzyme Corp | Vetores virais adenoassociados para tratar o glaucoma de miocilina (mioc) |
| IL251178B (en) * | 2014-09-16 | 2022-07-01 | Genzyme Corp | Adeno-associated viral vector for the treatment of glaucoma myocilin (myoc) |
| GB201809588D0 (en) * | 2018-06-12 | 2018-07-25 | Univ Bristol | Materials and methods for modulating intraocular and intracranial pressure |
| US12680122B2 (en) | 2019-10-08 | 2026-07-14 | Trustees Of Boston College | Proteins containing multiple, different unnatural amino acids and methods of making and using such proteins |
| JP2023517011A (ja) | 2020-03-05 | 2023-04-21 | ネオティーエックス セラピューティクス リミテッド | 免疫細胞を用いて癌を治療するための方法および組成物 |
| US20230235326A1 (en) * | 2020-06-05 | 2023-07-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for treating ocular diseases |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7465583B2 (en) * | 2000-06-01 | 2008-12-16 | The University Of North Carolina At Chapel Hill | Duplexed parvovirus vectors |
| US20040209832A1 (en) * | 2001-11-30 | 2004-10-21 | Mcswiggen James | RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
| US20050048529A1 (en) * | 2002-02-20 | 2005-03-03 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA) |
| US20040198682A1 (en) * | 2001-11-30 | 2004-10-07 | Mcswiggen James | RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA) |
| SG145713A1 (en) * | 2003-08-13 | 2008-09-29 | Univ Illinois | SILENCING OF TGFss TYPE II RECEPTOR EXPRESSION BY SIRNA |
| WO2006042252A2 (en) * | 2004-10-08 | 2006-04-20 | Potentia Pharmeceuticals, Inc. | Viral complement control proteins for eye disorders |
| TWI386225B (zh) * | 2004-12-23 | 2013-02-21 | Alcon Inc | 用於治療眼睛病症的結締組織生長因子（ＣＴＧＦ）ＲＮＡ干擾（ＲＮＡｉ）抑制技術 |
| TWI401316B (zh) * | 2004-12-23 | 2013-07-11 | Alcon Inc | 用於治療青光眼之血清澱粉樣蛋白Ａ的ＲＮＡｉ抑制作用 |
| TW200639253A (en) * | 2005-02-01 | 2006-11-16 | Alcon Inc | RNAi-mediated inhibition of ocular targets |
| CA2598234A1 (en) * | 2005-03-11 | 2006-09-21 | Alcon, Inc. | Rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma |
| GB0521351D0 (en) * | 2005-10-20 | 2005-11-30 | Genomica Sau | Modulation of TRPV expression levels |
| AR057252A1 (es) * | 2005-12-27 | 2007-11-21 | Alcon Mfg Ltd | Inhibicion de rho quinasa mediada por arni para el tratamiento de trastornos oculares |
| TW200731980A (en) * | 2005-12-29 | 2007-09-01 | Alcon Mfg Ltd | RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis |
| TW200808360A (en) * | 2006-04-13 | 2008-02-16 | Alcon Mfg Ltd | RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions |
| US8298818B2 (en) * | 2006-04-28 | 2012-10-30 | University Of Florida Research Foundation, Inc. | Self-complementary adeno-associated virus having a truncated CMV-chicken β-actin promoter |
| RU2469090C2 (ru) * | 2006-05-19 | 2012-12-10 | Алькон Рисерч, Лтд. | iPHK-ОПОСРЕДОВАННОЕ ИНГИБИРОВАНИЕ СВЯЗАННЫХ С ФАКТОРОМ НЕКРОЗА ОПУХОЛИ АЛЬФА СОСТОЯНИЙ |
| US20080051361A1 (en) * | 2006-08-24 | 2008-02-28 | Alcon Manufacturing, Ltd. | Rnai-mediated inhibition of gremlin for treatment of iop-related conditions |
| WO2008106102A2 (en) * | 2007-02-26 | 2008-09-04 | Quark Pharmaceuticals, Inc. | Inhibitors of rtp801 and their use in disease treatment |
| US7973019B1 (en) * | 2007-10-03 | 2011-07-05 | Alcon Research, Ltd. | Transferrin/transferrin receptor-mediated siRNA delivery |
| TW200932274A (en) * | 2007-12-18 | 2009-08-01 | Alcon Res Ltd | Interfering RNA delivery system and uses thereof |
-
2008
- 2008-10-01 AU AU2008308784A patent/AU2008308784B2/en not_active Ceased
- 2008-10-01 CA CA2694091A patent/CA2694091A1/en not_active Abandoned
- 2008-10-01 BR BRPI0817937 patent/BRPI0817937A2/pt not_active IP Right Cessation
- 2008-10-01 EP EP08835867A patent/EP2192926A1/en not_active Withdrawn
- 2008-10-01 CN CN200880110028A patent/CN101815536A/zh active Pending
- 2008-10-01 WO PCT/US2008/078380 patent/WO2009046059A1/en not_active Ceased
- 2008-10-01 JP JP2010527251A patent/JP2010540564A/ja active Pending
- 2008-10-01 US US12/243,100 patent/US20090087413A1/en not_active Abandoned
- 2008-10-01 MX MX2010001608A patent/MX2010001608A/es not_active Application Discontinuation
- 2008-10-01 KR KR1020107003620A patent/KR20100061792A/ko not_active Withdrawn
- 2008-10-01 RU RU2010117178/15A patent/RU2010117178A/ru not_active Application Discontinuation
-
2010
- 2010-01-20 ZA ZA2010/00423A patent/ZA201000423B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010117178A (ru) | Опосредованная самокомплементарными aav доставка молекул, интерферирующих рнк для лечения или профилактики глазных заболеваний | |
| Kang et al. | Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges | |
| Vicentini et al. | Delivery systems and local administration routes for therapeutic siRNA | |
| JP6924744B2 (ja) | Ｂ型肝炎ウイルスに対する組成物および薬剤ならびにその使用 | |
| JP2022501040A5 (enExample) | ||
| JP2013537423A5 (enExample) | ||
| NZ588583A (en) | Novel lipid formulations for nucleic acid delivery | |
| CA2752694A1 (en) | Synthetic rna-based agonists of tlr7 | |
| EA201000085A1 (ru) | dsPHK, ПРЕДНАЗНАЧЕННАЯ ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ИНФЕКЦИИ | |
| JP2014516954A5 (enExample) | ||
| RU2008150324A (ru) | Iphk-опосредованное ингибирование связанных с фактором некроза опухоли альфа состояний | |
| RU2013122656A (ru) | Композиции и способы доставки терапевтических средств | |
| JP2011516422A5 (enExample) | ||
| TW201907009A (zh) | 用於治療b型肝炎之治療組成物及方法 | |
| MX2012008652A (es) | Terapias para tratar infeccion por virus de hepatitis c. | |
| US9006202B2 (en) | Method and compositions for treating HIV infection | |
| Ma et al. | microRNA-579 upregulation mediates death of human macrophages with mycobacterium tuberculosis infection | |
| JP2025524740A (ja) | オリゴヌクレオチド送達増強剤、医薬組成物およびそれらを使用する方法 | |
| CN110506116A (zh) | 抑制masp2表达的核酸 | |
| CN108939074B (zh) | 治疗再生障碍性贫血的方法和药物组合物 | |
| CN114729360A (zh) | 降低病毒分子水平的方法 | |
| AU2022384619A1 (en) | Pharmaceutical combinations for treatment of hbv | |
| US11649457B2 (en) | Methods for treating SARS-CoV-2 infection | |
| US20240115596A1 (en) | Compositions and methods for treating sars-cov-2 infection | |
| Zhang et al. | Small nucleic acid drugs-the dawn of functional cure of chronic hepatitis B |